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Irs2-mediated insulin/IGF1 signaling in the CNS
modulates energy balance andglucose homeostasis;
however, the site for Irs2 function is unknown. The
hormone leptin mediates energy balance by acting
on leptin receptor (LepR-b)-expressing neurons. To
determine whether LepR-b neurons mediate the
metabolic actions of Irs2 in the brain, we utilized
Leprcre together with Irs2L/L to ablate Irs2 expression
in LepR-b neurons (LeprDIrs2). LeprDIrs2 mice devel-
oped obesity, glucose intolerance, and insulin resis-
tance. Leptin actionwasnot altered in youngLeprDIrs2
mice, although insulin-stimulated FoxO1 nuclear
exclusion was reduced in LeprDIrs2 mice. Indeed,
deletion of Foxo1 from LepR-b neurons in LeprDIrs2
mice normalized energy balance, glucose homeo-
stasis, and arcuate nucleus gene expression. Thus,
Irs2 signaling in LepR-b neurons plays a crucial role
in metabolic sensing and regulation. While not
required for leptin action, Irs2 suppresses FoxO1 sig-
naling in LepR-b neurons to promote energy balance
and metabolism.
INTRODUCTION
The rates of obesity and type 2 diabetes continue to increase
throughout the world and represent major contributors to
morbidity and mortality (White, 2003). It is thus crucial to under-
stand the processes that underlie energy homeostasis, as their
dysregulation can promote metabolic disease. Many aspects
of metabolism and energy balance are coordinated by the
central nervous system (CNS), where specialized sets of neurons
integrate information from circulating nutrients and hormones,
such as insulin and leptin, to control feeding, energy expendi-
ture, and nutrient homeostasis (Myers et al., 2009; Schwartz
and Porte, 2005).
Insulin and insulin-like growth factors (Igf1 and Igf2) act
through related tyrosine kinase receptors whose signalsCconverge on their downstream insulin receptor substrate
proteins, including insulin receptor substrate 1 (Irs1), Irs2, and
Irs4 (White et al., 2010). Tyrosine phosphorylated IRS proteins
recruit and activate phosphatidylinositol 3-kinase (PI3K) to
promote PDK1/Akt signaling, which mediates the phosphory-
lation, inactivation, and nuclear export of FoxO1 (forkhead box-
containing protein of the O subfamily-1) (Matsumoto and Accili,
2005). Of the IRS proteins, Irs1 plays a prominent role in organ-
ismal growth, especially in lean tissues (Tamemoto et al., 1994).
By comparison, Irs2 signaling is crucial for the proliferation and
survival of pancreatic beta cells (Hennige et al., 2003), fertility
(Burks et al., 2000), energy balance and glucose metabolism,
life span, and the progression of neurodegenerative disease
(Lin et al., 2004; Taguchi et al., 2007; Freude et al., 2009; Sada-
gurski et al., 2011). Regarding metabolism, disruption of Irs2 in
the brain produces an early-onset syndrome of obesity, insulin
resistance, and glucose intolerance, suggesting that central
Irs2 signaling is a crucial mediator of energy balance and meta-
bolic homeostasis (Taguchi et al., 2007).
While the importance of brain Irs2 for metabolic homeostasis
is clear, the relevant site of metabolic action has not been
revealed. The identity of this site is important in order to avoid
potential reproductive or neurodegenerative pathologies. A
great deal of attention has been paid to distinct populations of
arcuate (ARC) nucleus neurons that express proopiomelanocor-
tin (POMC) or agouti-related peptide (AgRP) (Morton et al.,
2006); however, deletion of Irs2 (or the insulin receptor, IR)
from these neurons inmice negligibly impactsmetabolic homeo-
stasis (Choudhury et al., 2005; Hill et al., 2010). Similarly, disrup-
tion of the PI3K/Akt─┤FoxO1 pathway (which lies downstream
of Irs2 and many other growth factors) in POMC and AgRP
neurons produces relatively subtle alterations in energy balance
and glucose homeostasis (Hill et al., 2008; Belgardt et al., 2008;
Cao et al., 2011; Al-Qassab et al., 2009). Thus, the relevant site at
which Irs2 signaling contributes to metabolic regulation must be
a distinct, or broader, set of neurons.
Leptin is a hormone produced by adipocytes in approximate
proportion to triglyceride energy stores, which acts via its
receptor, LepR-b, to diminish feeding, promote energy expendi-
ture, and modulate nutrient flux (Myers et al., 2009). Brain
LepR-b is required for these leptin actions (Myers et al., 2009;
Cohen et al., 2001; de Luca et al., 2005). While POMC andell Metabolism 15, 703–712, May 2, 2012 ª2012 Elsevier Inc. 703
Figure 1. LeprDIrs2 Mice Are Obese
(A) Schematic representation of our breeding strategy to generate LeprDIrs2
mice.
(B) Average body weights of male LeprDIrs2 mice (closed circles) and control
Irs2L/L mice (open circles) on regular chow diet was determined in each
average age group by generalized linear regression (SPSS, v. 19). The number
of mice in each group is indicated in parentheses (mean ± SD; *, Bonferroni
p < 0.001).
(C and D) Percent body fat (C) and (D) lean body mass (D) were determined by
DEXA with 12-week-old Irs2L/L (n = 12) and LeprDIrs2 (n = 12) mice (mean ±
SEM; *p < 0.05).
(E) Serum leptin levels of 12-week-old male Irs2L/L (n = 7) and LeprDIrs2 (n = 7)
mice (mean ± SEM; *p < 0.05).
(F) Food intake over 48 hr in 12-week-old male Irs2L/L (n = 12) and LeprDIrs2
(n = 12) mice fed regular chow diet (mean ± SEM; *p < 0.05).
See also Figure S1.
Cell Metabolism
The Role of IRS2 Signaling in LEPR-B NeuronsAgRP neurons are crucial for the control of energy homeostasis
and leptin action via POMC and AgRP neurons has been studied
extensively (Elmquist et al., 2005), it is clear that direct leptin
action on these neurons contributes only modestly to overall lep-
tin action (Myers et al., 2009; Balthasar et al., 2004; van de Wall704 Cell Metabolism 15, 703–712, May 2, 2012 ª2012 Elsevier Inc.et al., 2008). Indeed, while LepR-b neurons are only found in rela-
tively few areas of the CNS, POMC and AgRP neurons represent
only a small percentage of total LepR-b neurons (Myers et al.,
2009; Patterson et al., 2011; Scott et al., 2009). Furthermore,
leptin action via non-POMC, non-AgRP neruons plays a crucial
role in energy balance and the control of the hypothalamic mel-
anocortin system (Vong et al., 2011). Overall, the hypothalamic,
midbrain, and brainstem sites in which LepR-b neurons are
located are known to play crucial roles in metabolism and energy
balance. In aggregate, LepR-b neurons sense and integrate
signals relevant to nutrient homeostasis to control energy
balance and metabolism.
Given the crucial overlapping roles for brain leptin and insulin/
Igf signaling in the control of metabolism and energy balance,
along with the presumed importance of LepR-b neurons for the
sensing and modulation of nutrient homeostasis, we hypothe-
sized that LepR-b neurons represent the crucial locus for Irs2
signaling to control metabolism. We therefore deleted Irs2
specifically in LepR-b neurons and examined energy balance
and metabolism in these mice, and investigated whether
FoxO1 contributes to their phenotype.
RESULTS
Generation of LeprDIrs2 Mice
To inactivate Irs2 specifically in LepR-b neurons, we crossed
Leprcre, which drives the expression of cre recombinase in
LepR-b cells, onto the Irs2L/L background, in which the Irs2
coding sequence was surrounded by LoxP sites (Figure 1A)
(Leshan et al., 2006, 2009; Dong et al., 2006). Since Leprcremedi-
ates modest cre expression and cre-mediated excision by this
allele is more complete in Leprcre/cre homozygous animals, we
compared Leprcre/cre,Irs2L/L (LeprDIrs2) mice to Irs2L/L control
littermates. Leprcre does not disrupt LepR-b expression or func-
tion, and Leprcre/cre animals never displayed a pathological
phenotype (Leshan et al., 2006).
LeprDIrs2 mice were born at the expected Mendelian ratio,
were of normal size and appearance, and were fertile. PCR
analysis confirmed the excision of both Irs2L alleles in Lepr-con-
taining brain regions of LeprDIrs2 mice, and the reduction in Irs2
messenger RNA (mRNA) and Irs2 protein in the hypothalamus,
but not in other tissues or irrelevant brain areas, such as the
cortex (Figure S1 available online). Within the hypothalamus,
Irs2 expression was substantially but not entirely reduced (Fig-
ure S1), consistent with the percentage of total hypothalamic
neurons that express LepR-b (Myers et al., 2009; Patterson
et al., 2011; Scott et al., 2009).
Obesity in LeprDIrs2 Mice
To assess the impact of Irs2 deletion in LepR-b neurons on
energy homeostasis, we compared body weight and composi-
tion of control and LeprDIrs2mice.Male LeprDIrs2micewere about
20% heavier than controls between 4 and 24 weeks of age (Fig-
ure 1B). As shown previously for mice null for Irs2 throughout
the brain (Lin et al., 2004; Taguchi et al., 2007), 12-week-old
male LeprDIrs2 mice displayed more body adiposity but normal
lean mass relative to controls (Figures 1C and 1D). Circulating
leptin concentrations were also increased (Figure 1E). However,
LeprDIrs2 mice consumed approximately 20% more chow than
Figure 2. Energy Expenditure in LeprDIrs2 Mice
(A–D) Twenty-four-week-old male mice of the indicated
genotype were monitored for 72 hr in the CLAMS (n = 10/
genotype) to assess oxygen consumption (O2, l/kg/hr) (A),
carbon dioxide production (CO2, l/kg/hr) (B), heat
production (kcal/kg 0.75) (C), and locomotor activity (D)
during the light and dark cycles. Each group was analyzed
by generalized linear regression (SPSS, v. 19), (mean ±
SD; *, Bonferroni p < 0.001).
(E) Representative H&E staining of brown adipose tissue
(BAT) of Irs2L/L (left) and LeprDIrs2 mice (right) mice aged
24 weeks. Scale bars represent 500 mm.
(F) Levels of mRNA by semiquantitative RT-PCR of Ucp1
and Ppargc1a from BAT of 24-week-old Irs2L/L and
LeprDIrs2mice (n = 6). Data are presented as mean ± SEM;
*p < 0.05.
See also Figure S2.
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The Role of IRS2 Signaling in LEPR-B Neuronscontrols during a 48 hr interval (Figure 1F), suggesting that hyper-
phagia contributed to their obesity. Thus, LeprDIrs2 mice devel-
oped hyperphagic obesity from an early age, consistent with an
important role for Irs2-mediated insulin/Igf signaling in LepR-b
neurons for the control of food intake and energy balance.
To determine the role for Irs2 in LepR-b neurons for the control
of energy utilization, we analyzed components of energy expen-
diture in ad libitum-fed 6-month-old male control and LeprDIrs2
mice (Figures 2A–2D). During the dark and the light phases, O2
consumption, CO2 production, and heat generation were
reduced significantly in LeprDIrs2mice compared to control litter-
mates. Furthermore, ambulatory movement was reduced by
more than 50% in LeprDIrs2 mice. The decreased metabolic
rate and heat production of LeprDIrs2 mice revealed a potential
impairment of brown adipose tissue (BAT) function in these
animals. Indeed, BAT from young and old LeprDIrs2 mice con-
tained large, unilocular, lipid-filled vacuoles that resemble those
in white adipocytes (Figures 2E and S2). Moreover, the expres-
sion of Ucp1 (mitochondrial uncoupling protein 1) and Pgc1a
(Ppargc1a, peroxisome proliferator-activated receptor gamma,
coactivator 1 alpha) was reduced significantly in the BAT of
LeprDIrs2 mice compared to controls (Figure 2F), suggesting
that Irs2 signaling in LepR-b neurons is crucial for the control
of BAT function, which presumably contributes to the decreased
energy expenditure in these animals. Thus the combination of
increased feeding and decreased energy expenditure via
multiple mechanisms promotes obesity in LeprDIrs2 mice,
demonstrating the importance of Irs2 signaling in LepR-b
neurons for the overall control of energy balance.Cell Metabolism 1Impaired Glucose Homeostasis with
Preserved Endocrine Function in
LeprDIrs2 Mice
Next we investigated glucose homeostasis in
LeprDIrs2mice. While the blood glucose concen-
tration was indistinguishable between ad libi-
tum-fed control and LeprDIrs2 mice at 6 weeks
of age (151 ± 13.4 and 152 ± 5.5 respectively),
LeprDIrs2mice displayed substantial hyperinsuli-
nemia at baseline, as well as glucose intoler-
ance and insulin resistance (Figures 3A, 3C,
and 3E). By 6 months of age, LeprDIrs2mice dis-played elevated fasting blood glucose concentrations (Cntr, 96 ±
14.8; LeprDIrs2, 171.25 ± 20.5), increased circulating insulin,
insulin resistance, and glucose intolerance (Figures 3B, 3D,
3F). Hyperinsulinemia in the LeprDIrs2mice suggested an impair-
ment of insulin sensitivity and glucose handling independent of
any changes in islet function. However, while islet area was
normal in young mice, islet area in older (1 year) mice increased
commensurate with a compensatory increase in insulin produc-
tion (Figure S3).
In contrast to the decreased insulin sensitivity and impaired
glycemic control in LeprDIrs2 mice, other measures of endocrine
function were not impaired in these animals (Figure S4). All
matings between Irs2L/L and LeprDIrs2 mice produced normal-
sized, healthy litters within 4 weeks (Table S1), and LeprDIrs2
femalesdisplayednormal reproductiveorgansandonsetof estrus
(Figures S4C and S4D). Furthermore, serum thyroxine and
corticosterone concentrations were indistinguishable between
LeprDIrs2 and control mice (Figurea S4A and S4B). Thus, whereas
Irs2 signaling in LepR-b neurons was crucial for the control of
energy balance and glucose homeostasis, it did not contribute
to the wider control of endocrine function. As the absence of
leptin action in LepR-b neurons alters dramatically these endo-
crine axes along with nutrient homeostasis (Ahima and Flier,
2000), these findings suggest that leptin and insulin/Igf/Irs2
signaling mediate separate functions in LepR-b neurons.
LepR-b Signaling and Leptin Sensitivity in LeprDIrs2Mice
Given the distinct phenotypes resulting from the absence of
leptin action compared to Irs2 signaling in LepR-b neurons, we5, 703–712, May 2, 2012 ª2012 Elsevier Inc. 705
Figure 3. Glucose Homeostasis in LeprDIrs2 Mice
(A and B) Fasting serum insulin levels (n = 10/genotype)
for 6-week-old male mice (A) and 1-year-old mice (n = 5/
genotype) (B) of the indicated genotypes.
(C and D) Glucose tolerance test of 6-week-old male mice
(C) or 24-week-oldmice (D) of the indicated genotypes (n =
10/genotype).
(E and F) Insulin tolerance test of 7- to 8-week-oldmice (n =
9–10/genotype) (E) or 24-week-old mice (n = 8–10/geno-
type) (F).
Data are expressed as mean ± SEM Irs2L/L mice versus
LeprDIrs2 mice: *p < 0.05; **p < 0.01. See also Figures S3
and S4 and Table S1.
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The Role of IRS2 Signaling in LEPR-B Neuronsexamined the response to leptin in LeprDIrs2 mice to determine
whether disruption of Irs2 in LepR-b neurons interferes with
LepR-b signaling or anorectic leptin action. Since obesity itself
impairs each of these aspects of leptin action by a number of
mechanisms, we assayed leptin responsiveness in young
animals to mitigate against this possibility (Myers et al., 2010,
2012).
Leptin binding to LepR-b activates an associated Jak2
tyrosine kinase, thereby promoting the phosphorylation of
LepR-b and the recruitment and tyrosine phosphorylation of
STAT3 (signal transducer and activator of transcription-3) (Rob-
ertson et al., 2008). The leptin-stimulated accumulation of
pSTAT3 in the brain reflects cell-autonomous LepR-b signaling,
which is impaired in states associated with diminished leptin
action (Vaisse et al., 1996; Mu¨nzberg et al., 2004; Myers et al.,
2010, 2012). Acute leptin treatment promoted similar levels of
hypothalamic pSTAT3 in control and LeprDIrs2 mice (Figures 4A
and 4B). Leptin was similarly effective in control and LeprDIrs2
mice for the stimulation of cFos-immunoreactivity, a measure
of neuronal activation (Figure S5). Thus, Irs2 in LepR-b neurons
was not required for acute LepR-b signaling.
To examine the anorectic response to exogenous leptin, we
administered leptin (5 mg/kg, intraperitoneal [i.p.]) to 6-week-
old mice twice daily for 3 days. In control animals, this treatment
promoted the expected decrease in food intake and weight
relative to vehicle-treated animals (Figures 4C and 4D). Impor-
tantly, LeprDIrs2 mice responded to leptin treatment in a similar
manner, demonstrating both decreased food intake and body706 Cell Metabolism 15, 703–712, May 2, 2012 ª2012 Elsevier Inc.weight during the treatment. Thus, Irs2 signaling
in LepR-b neurons was not required for the
ability of leptin to acutely suppress food intake
and body weight, suggesting that Irs2 signaling
in LepR-b neurons was functionally separable
from leptin signaling.
FoxO1 Signaling in LeprDIrs2 Mice
Insulin/Igf stimulation leads to the tyrosine
phosphorylation of Irs2 and to the activation
of the PI3K cascade, which inhibits FoxO1
by promoting its phosphorylation-dependent
export from the nucleus (Brunet et al., 2001;
Cheng et al., 2010). To establish whether inacti-
vation of Irs2 dysregulates insulin-like signaling
in LepR-b neurons, we investigated the distribu-tion of FoxO1 between the nuclear and cytoplasmic compart-
ments in ARC LepR-b neurons of control (Leprcre) and LeprDIrs2
mice, which were on the cre-inducible ROSA26-EGFP back-
ground to reveal LepR-b neurons by the expression of EGFP
(LeprEGFP and LeprEGFPDIrs2mice, respectively) (Figure 5). Before
insulin treatment, about 50% of the ARC LepR-b neurons con-
tained nuclear FoxO1 in fasted control and LeprEGFPDIrs2 mice.
After insulin injection into the lateral ventricle, nuclear FoxO1
was detected in only 30% of the ARC LepR-b neurons of control
mice. By contrast, insulin treatment of LeprEGFPDIrs2mice did not
reduce the percentage of ARC LepR-b neurons containing
nuclear FoxO1. These results are consistent with the disruption
of the Irs2/PI3K/Akt─┤FoxO1 pathway, rather than interfer-
ence with leptin signaling and action, in the LepR-b neurons of
LeprDIrs2 mice.
Restoration of Energy Homeostasis in LeprDIrs2 Mice by
Deletion of FoxO1 from LepR-b Neurons
Since a major role for Irs2 signaling in other tissues is the
suppression of FoxO1 action (Dong et al., 2008), we examined
whether FoxO1 mediated the effects of Irs2 in LepR-b neurons.
We bred our LeprDIrs2 mice onto the FoxO1L/L background, in
which cre recombinase excises sequences crucial for FoxO1
expression, thereby producing ‘‘double-knockout’’ mice lacking
both Irs2 and FoxO1 in LepR-b neurons (LeprDIrs2,DFoxO1 mice).
PCR analysis confirmed the excision of FoxO1L in Lepr-contain-
ing hypothalamic regions of LeprDIrs2,DFoxO1mice and the reduc-
tion of FoxO1 protein in the ARC of these animals (Figure S6).
Figure 4. LepR-b Signaling and Leptin
Sensitivity in LeprDIrs2 Mice
(A) Immunostaining for pSTAT3 in 6-week-old
mice of the indicated genotypes injected intra-
peritoneally with vehicle or leptin (5 mg/kg, i.p.,
2 hr, third cerebral ventricle). Representative
images from the hypothalamus are shown. Scale
bars represent 100 mm.
(B) Quantification of pSTAT3 immunoreactivity (n =
4/genotype).
(C and D) Cumulative food intake and reduction in
body weight were measured over a 3 day period of
treatment with leptin (5 mg/kg i.p.; BID) or vehicle
in 6-week-old male mice of the indicated geno-
types.
Data are presented as mean ± SEM; *p < 0.05;
**p < 0.01. See also Figure S5.
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The Role of IRS2 Signaling in LEPR-B NeuronsWhereas LeprDIrs2mice showed the expected increase in body
weight compared to control littermates, LeprDIrs2DFoxO1 animals
displayed normal body weight (Figure 6A). All control genotypes
exhibited indistinguishable (normal) body weight (Figure S7).
Deletion of FoxO1 from LepR-b neurons also prevented hyper-
phagia and normalized VO2 and VCO2 in the Lepr
DIrs2DFoxO1
mice (Figures 6B–6D). Moreover, while blood glucose concen-
trations in 16-week-old LeprDIrs2 mice were dramatically
increased during the glucose tolerance test compared to
controls, there was no difference between the controls and
LeprDIrs2DFoxO1 mice, and fasting insulin concentrations were
normalized in male LeprDIrs2DFoxO1 mice (Figures 6E and 6F).
Overall, these findings indicate that suppression of FoxO1
activity in LepR-b neurons is the principal means by which Irs2
controls energy homeostasis.
Control of ARC Neuropeptide Expression by Irs2
and FoxO1 in LepR-b Neurons
To elucidate themechanisms bywhich Irs2 and FoxO1 in LepR-b
neurons controls energy balance, we employed qPCR to
examine the expression of ARC genes involved in the control of
energy homeostasis (Figure 7). This analysis revealed the
decreased expression of Pomc and increased expression of
Agrp in the hypothalamus of LeprDIrs2, but not LeprDIrs2DFoxO1
mice. While Socs3 expression tended to be slightly reduced in
LeprDIrs2 mice compared to controls, the difference was not
statistically significant (Cntr, 0.04 ± 0.009; LeprDIrs2D, 0.026 ±
0.005; p value = 0.06). Thus, elimination of Irs2 signaling in
LepR-bneurons interfereswith thenormal control of thehypotha-
lamic melanocortin system, and the removal of FoxO1 prevents
this dysregulation, suggesting that Irs2─┤FoxO1 signaling in
LepR-b neurons is crucial for the regulation of this system.Cell Metabolism 15, 703DISCUSSION
Our data reveal that Irs2 signaling in
LepR-b neurons is crucial for the control
of energy balance and glucose homeo-
stasis, since deletion of Irs2 from this
restricted subset of CNS neurons dysre-
gulates gene expression within the hypo-
thalamic melanocortin system, increasesfeeding, decreases energy expenditure, and promotes insulin
resistance. Furthermore, the suppression of FoxO1-mediated
signaling represents a crucial mechanism for Irs2 action in these
neurons.
The manipulation of Irs2 to probe the role for insulin/Igf
signaling in neurons has a number of advantages over other
approaches. First, given the redundancy and cross-reactivity
of insulin and insulin-like growth factors for IR and Igf1R (LeRoith
et al., 1994), the deletion of either of these receptors alone in the
brain produces relatively modest effects (Bru¨ning et al., 2000;
Kappeler et al., 2008) and fails to reveal the full physiologic role
for neuronal insulin and Igf signaling in the control of metabolism.
Similarly, direct manipulation of the downstream PI3K pathway
interferes not only with insulin and Igf signaling, but also dysregu-
lates signals generated by other important growth factor and
cytokine receptor pathways, including those of the NGF,
PDGF, and FGF families, among others (Foukas and Withers,
2010). Thus, in addition to being genetically complex (due to
the number of regulatory and catalytic PI3K subunits and
downstream effector proteins), manipulation of PI3K and its
downstream effectors interferes with the action of multiple
receptor systems likely to be important for neuronal growth
and differentiation (Cantley, 2002; Brunet et al., 2001). Deletion
of Irs2 from LepR-b neurons in LeprDIrs2 mice reveals the crucial
role for insulin/Igf signals specifically in LepR-b neurons for
energy balance and metabolism. Moreover, the abrogation of
this phenotype by deletion of FoxO1 from these neurons in
LeprDIrs2DFoxO1 mice reveals that the inhibition of FoxO1 action
represents the main function of Irs2 signaling in LepR-b neurons.
Many reports suggest the importance of brain insulin/Igf
signaling in the control of body weight and metabolism (Bru¨ning
et al., 2000; Taguchi and White, 2008; Schwartz and Porte,–712, May 2, 2012 ª2012 Elsevier Inc. 707
Figure 5. FoxO1 Signaling in LeprDIrs2 Mice
(A) Immunofluorescence for FoxO1 (red) in 6-week-
old control LeprEGFP and LeprEGFPDIrs2 mice in-
jected intracerebroventricularly with vehicle or
insulin (300 mU; 1 hr). Representative images from
the hypothalamus of LeprEGFP and LeprEGFPDIrs2
mice are shown. Scale bars represent 100 mm. The
lower (small) panels are digital zooms of boxed
areas from the top panel, showing FoxO1 (red)
alone (left) or merged with EGFP (green) (right) in
6-week-old mice of the indicated genotypes.
(B) Quantification of LepR-b/EGFP neurons con-
taining nuclear FoxO1 immunoreactivity (n = 4/
genotype). Data are presented as mean ± SEM;
*p < 0.05.
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The Role of IRS2 Signaling in LEPR-B Neurons2005); however, the site(s) of action at which these signals act to
control metabolic homeostasis have remained unclear. While
a great deal of research in the control of metabolism by the brain,
and especially by insulin action in the brain, has focused upon
the POMC and AgRP neurons of the ARC, ablation of IR or Irs2
from these neurons has little effect on body weight or glucose
homeostasis (Hill et al., 2010; Plum et al., 2005; Choudhury
et al., 2005; Ko¨nner et al., 2007). Similarly, deletion of the insulin
receptor from SF1 neurons of the VMH promotes modest weight
gain on a high-fat diet, but does not significantly alter energy
balance or insulin sensitivity in chow-fed animals (Klo¨ckener
et al., 2011). While insulin signaling in TH-expressing catechol-
aminergic neurons is important for the control of mesolimbic
dopamine (DA) signaling, lack of IR signaling in these neurons
also fails to change measures of adiposity or glucose homeo-
stasis (Ko¨nner et al., 2011). We thus reasoned that the important
site of Irs2 signaling in the brain likely represented amore distrib-708 Cell Metabolism 15, 703–712, May 2, 2012 ª2012 Elsevier Inc.uted set of neurons involved in the
sensing and regulation of metabolic cues.
Leptin is a crucial signal of energy
balance and metabolic status, and it acts
via a distributed set of LepR-b-express-
ing neurons that represent specialized
subpopulations of neurons within areas
of the brain known to integrate signals of
energy homeostasis (Myers et al., 2009;
Patterson et al., 2011; Scott et al.,
2009). LepR-b neurons include those
that express AgRP (as well as subsets of
POMC, SF-1, and TH neurons), but also
include other metabolically important
neurons in the ARC, DMH, and else-
where. The strong phenotype resulting
from Irs2 deletion in LepR-b neurons in
LeprDIrs2 mice thus reveals that the meta-
bolically relevant insulin/Igf signaling in
the brain (like leptin signaling) is distrib-
uted across multiple groups of special-
ized neurons that sense and control
metabolism. While technical limitations
prevent the identification of specific
neurons that contain both LepR-b and
Irs2, they are largely codistributed withinthe ARC, VMH, and DMH, suggesting that LepR-b neurons in
these areas, which are known to control energy balance and
metabolism, likely mediate important aspects of Irs2 action.
Indeed, our findings of decreased ARC Pomc expression
and increased Agrp expression in the LeprDIrs2 mice, but not
LeprDIrs2DFoxO1 mice, suggests an important role for Irs2
signaling in LepR-b neurons for the control of hypothalamic
melanocortin action. LepR-b neurons in the ARC, VMH, and
DMH contribute to the regulation of the hypothalamic melano-
cortin system, at least in part by indirect action via non-POMC,
non-AgRP LepR-b neurons (Vong et al., 2011; Sternson et al.,
2005), where Irs2 contributes importantly.
In addition to early defects in energy balance that result from
a combination of increased energy intake and decreased energy
expenditure by multiple mechanisms (activity, heat production,
etc.), our data reveal early insulin resistance in the LeprDIrs2
mice that develops concomitantly with weight gain and obesity,
Figure 6. Restoration of Energy Homeostasis in
LeprDIrs2 Mice by Deletion of FoxO1 from LepR-
b Neurons
(A and B) Parameters of energy balance for 16-week-old
chow-fed male mice of the indicated genotypes (n = 10/
genotype): body weight (A) and food intake (B).
(C and D) Parameters of energy balance for 16-week-old
chow-fed male mice of the indicated genotypes: oxygen
consumption (O2, L,kg
1,h1) (C) and carbon dioxide
production (CO2, L,kg
1,h1) (D) during the dark cycle.
(E and F) Glucose tolerance test (E) and fasting serum
insulin concentrations (F) in 16-week-old mice of the
indicated genotypes (n = 8–10/genotype).
Data are presented as mean ± SEM; *p < 0.05. See also
Figures S6 and S7.
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insulin resistance. While it is not clear from our present results
which tissue(s) contribute to this diminished insulin action, others
have previously suggested that altered hepatic insulin action and
glucose handling interferes with glucose homeostasis in animals
with defects in hypothalamic insulin/PI3K/Akt─┤FoxO1
signaling (Ko¨nner et al., 2007; Plum et al., 2006).
Although Irs2 is essential for pancreatic beta cell proliferation
and survival (Hennige et al., 2003; Lin et al., 2004), the metabolic
phenotype of the LeprDIrs2 mice does not include beta cell defi-
ciency. Indeed, we have failed to observe islet LepR-b expres-
sion by the criterion of Leprcre-mediated reporter expression
(data not shown). Moreover, circulating insulin concentrations
are elevated appropriately to compensate for the increased
adiposity and insulin resistance, and LeprDIrs2 mice display
increased islet size only at advanced ages. Indeed, we have
failed to observe islet LepR-b expression by the criterion of
Leprcre-mediated reporter expression (data not shown). Thus,
the previously suggested roles for islet LepR-b expression in
physiology likely represent artifacts of cre alleles that mediate
recombination in (poorly characterized) groups of brain LepR-b
neurons (Covey et al., 2006; Wicksteed et al., 2010). The finding
of obesity and insulin resistance in RIPcre,Irs2L/L animals after
rescue of beta cell Irs2 suggests that the poorly characterized
set of RIPcre-expressing LepR-b neurons may be especiallyCell Metabolism 1important for the metabolic action of insulin/Igf
signaling in the brain (Lin et al., 2004; Wicksteed
et al., 2010).
While the crucial set of neurons that mediates
the metabolic effects of Irs2 signaling in the
brain are by definition those that mediate leptin
action (leptin action is mediated by LepR-b
and thus by LepR-b neurons), the normal
response of young LeprDIrs2mice to the anoretic
effects of leptin suggests that Irs2 is not required
for leptin action. Furthermore, while interference
with leptin action in these LepR-b neurons
promotes endocrine and reproductive dysfunc-
tion, in addition to obesity and insulin resistance
(Cohen et al., 2001; van de Wall et al., 2008),
deletion of Irs2 and interference with insulin/Igf
signaling in LepR-b neurons in LeprDIrs2 mice
does not alter the thyroid, adrenal, or reproduc-tive axes. While leptin can promote some Irs2/PI3K signaling
(Niswender et al., 2001), the ability of leptin to stimulate this path-
way pales by comparison to that of insulin, suggesting that Irs2
functions primarily to mediate insulin/Igf signaling in leptin-
responsive neurons, rather than functioning as a direct mediator
of LepR-b signaling. Indeed, while the hypothalamic application
of PI3K inhibitors or the genetic blockade of PI3K in some leptin-
responsive neurons impairs the acute anorectic response to
leptin, these manipulations have little effect on baseline leptin
action or energy balance (Morton et al., 2005; Niswender et al.,
2001, 2003). Thus, while Irs2 signaling in LepR-b neurons is
crucial for metabolic signaling, this pathway does not appear
to play a direct role in leptin action, per se. Hence, while Irs2
and LepR-b signaling act in the same neurons to control a variety
of metabolic parameters, the requirement for Irs2 is independent
from the cellular action of leptin. Despite continued normal
LepR-b signaling in the absence of Irs2, the net tone of the
neuron is altered without Irs2 signaling, however.
While the hyperleptinemia of LeprDIrs2 mice meets one defini-
tion of leptin resistance (Myers et al., 2010, 2012), the unaltered
leptin sensitivity in these animals at a young age, prior to
exposure to chronic obesity, suggests that the elevated leptin
concentration in these animals mainly reflects their increased
adipose mass, rather than indicating a primary lesion in leptin
action (Myers et al., 2010, 2012). The finding of hyperleptinemia5, 703–712, May 2, 2012 ª2012 Elsevier Inc. 709
Figure 7. Hypothalamic Expression of Agrp and Pomc
Levels of mRNA by semiquantitative RT-PCR of Agrp (A) and Pomc (B) from
hypothalamus of 16-week-old chow-fedmale mice of the indicated genotypes
(n = 6). Data are presented as mean ± SEM; *p < 0.05.
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of clearly distinguishing between blood leptin levels and leptin
action in young animals when assessing leptin resistance or
sensitivity, as processes unrelated to cellular leptin signaling or
physiologic leptin responsiveness may alter adiposity (Myers
et al., 2010).
Overall, our findings reveal that LepR-b neurons represent
the crucial mediators of brain insulin/Igf signaling in the control
of energy balance and glucose homeostasis, revealing the distri-
bution of metabolically important insulin/Igf signaling across
a network of specialized neurons that sense and control metab-
olism. Furthermore, the essential function of insulin/Igf/Irs2
signaling in these neurons is not in the potentiation of leptin
signaling, but in the suppression of FoxO1 action.EXPERIMENTAL PROCEDURES
Animals
Leprcre, Irs2L/L, and Leprcre mice on the ROSA26tm2sho background (LeprEGFP)
were described previously (Dong et al., 2006; Leshan et al., 2009). Mice were
bred in our colony at Children’s Hospital Boston, the Harvard School of Public
Health, or in the Unit for Laboratory Animal Medicine (ULAM) at the University
of Michigan. All animals were handled in accordance with all procedures
approved by the appropriate Institutional Animal Care and Use Committee
(IACUC). Animals were fed breeder chow diet containing 9 kcal % fat
(Research Diets).
Metabolic Analysis
Lean and fat body mass were assessed by Dual-Energy X-ray Absorptiometry
(DEXA, GE Lunar) as previously described (Dong et al., 2008). Blood glucose
levels were measured on random-fed or overnight-fasted animals in mouse-
tail blood using Glucometer Elite (Bayer). An i.p. glucose tolerance test was
performed onmice fasted for 16 hr overnight. Animals were then injected intra-
peritoneally with D-glucose (2 g/kg) and blood glucose levels were measured
(Withers et al., 1999). For insulin tolerance tests, mice were fasted for a 4 hr
period in the light cycle before i.p. injections of insulin (Humulin R, 0.8 U/kg)710 Cell Metabolism 15, 703–712, May 2, 2012 ª2012 Elsevier Inc.diluted in sterile saline. Blood glucose concentrations were measured at indi-
cated time points. Blood insulin and leptin levels were determined on serum
from tail vein bleeds with a Rat Insulin ELISA kit and Mouse Leptin ELISA kit
(Crystal Chem). For food intake measurements, mice were singly housed
and food intake was measured for 2 consecutive days. For peripheral leptin
treatment, mice were treated with either 5 mg/kg recombinant mouse leptin
(provided by Dr. A Parlow, National Hormone and Pituitary Program, Torrance,
CA) or vehicle, injected i.p. twice per day for 3 consecutive days. Food and
body weights were recorded before injection and during the treatment period.
Energy Expenditure and Locomotor Activity
As previously described (Sadagurski et al., 2010), physical activity and energy
expenditure were performed over a 72 hr period with a Comprehensive
Laboratory Animal Monitoring System (CLAMS, Oxymax Windows 3.0.3;
Columbus Instruments, OH). Mice were housed individually at room tempera-
ture (22C) under an alternating 12 hr light/12 hr dark cycle. Heat production
was measured and normalized by metabolic body size (WT0.75) to determine
the energy expenditure (Xu et al., 2010). For brown adipose tissue histology
the hematoxylin and eosin (H&E) staining was performed with paraffin-
embedded brown adipose tissue sections as previously described (Balthasar
et al., 2004).
RNA Extraction and qPCR
Total RNA was extracted from brown adipose tissue or from hypothalamus
with Trizol (GIBCO BRL), and 1 mg samples were converted to complementary
DNA (cDNA) with the iscript cDNA kit (Bio-Rad Laboratories). Sample cDNAs
were analyzed in triplicate via quantitative RT-PCR for Ucp1 and Ppargc1a in
brown adipose tissue and for Pomc and Agrp in hypothalamus with custom-
ized primers as previously described (Sadagurski et al., 2010). Actin gene
expression was used to normalize RNA content and the relative gene product
amounts were reported as mean ± SEM of several animals.
Intracerebral Cannulation and Insulin Administration
As described previously (Leinninger et al., 2009), adult LeprDIrs2 or control mice
were anesthetized with an isoflurane vaporizer and placed in a stereotaxic
frame (Kopf Instruments). After the skull was exposed and coordinates for
bregma were determined, a 26 g steel guide cannula with stylet (Plastics
One) was lowered toward the right lateral ventricle using the following coordi-
nates from bregma: 0.6 mm posterior, 1.0 mm lateral, 2.1 mm ventral. The
guide cannula was cemented to the skull with dental acrylic, and the skin
surrounding the cannula was closed with sutures. Postsurgery, mice were
singly housed and received Buprenex analgesia. Animals’ body weights and
food intake were monitored daily with additional daily handling that included
removal and replacement of the stylet. Two weeks postsurgery, 24 hr before
experimental treatment, correct cannula placement was confirmed based on
drinking response after angiotensin II injection. On the day of treatment,
animals were fasted for 4 hr, followed by administration of insulin (300 mU)
or an equivalent volume of saline. One hour postinjection, animals were
anesthetized and perfused as detailed below.
Perfusion and Immunolabeling
Mice were anesthetized with an overdose of i.p. pentobarbital and transcar-
dially perfused with 10% neutral buffered formalin as previously described
(Mu¨nzberg et al., 2007). In brief, brains were postfixed, dehydrated, then
sectioned coronally (30 mm) with a sliding microtome followed by immunohis-
tochemical or immunofluoresent analysis as described. For immunohisto-
chemical labeling, free-floating brain sections were pretreated by sequential
incubations in 0.3% H2O2/1% NaOH, 0.3% glycine, 0.03% SDS, followed by
blocking in normal donkey serum (NDS) and incubation in primary antibodies
(anti-pSTAT3, Cell Signaling; anti-cFos, Calbiochem). Incubation in biotiny-
lated donkey anti-rabbit (Jackson Immunoresearch) preceded avidin-biotin-
complex (Vectastain) and development with metal-enhanced DAB (Thermo
Scientific). For immunofluorescent detection of rabbit anti-FoxO1 (Cell
Signaling) and chicken anti-GFP (Abcam), free-floating brain sections were
blocked in NDS and incubated in primary antibodies, followed by Alexa-
Fluor-conjugated secondary antibodies (Invitrogen). Sections were mounted
onto Superfrost Plus slides (Fisher Scientific) and coverslipped with ProLong
Antifade mounting medium (Invitrogen). Microscopic images were obtained
Cell Metabolism
The Role of IRS2 Signaling in LEPR-B Neuronswith an Olympus FluoView 500 Laser Scanning Confocal Microscope
(Olympus) at theMichigan Diabetes Research and Training CenterMicroscopy
Core. The images were quantified with Imaris (versions 6.4 and 7.0; Bitplane),
using the function spot to count nuclei and surface to measure the area or the
volume of the different objects.
Statistical Analysis
Unless otherwise stated mean values ± SEM were used to make comparisons
between two groups; significance was determined by a Student’s t test.
A p value less than 0.05 was considered statistically significant. Generalized
linear regression (SPSS, v. 19) was used to identify significant differences in
mice body weight and energy expenditure parameters.
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